268 related articles for article (PubMed ID: 31447125)
1. The art of partnerships for vaccines.
Pagliusi S; Che Y; Dong S
Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
[TBL] [Abstract][Full Text] [Related]
2. Vaccines, inspiring innovation in health.
Pagliusi S; Dennehy M; Kim H;
Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
[TBL] [Abstract][Full Text] [Related]
3. Vaccines: Shaping global health.
Pagliusi S; Ting CC; Lobos F;
Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
[TBL] [Abstract][Full Text] [Related]
4. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
[TBL] [Abstract][Full Text] [Related]
5. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
Pagliusi S; Dennehy M; Homma A
Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016
[TBL] [Abstract][Full Text] [Related]
6. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.
Pagliusi S; Ting CC; Khomvilai S;
Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496
[TBL] [Abstract][Full Text] [Related]
7. Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
Pagliusi S; Rustan R; Huang W; Nguyen T;
Vaccine; 2014 Nov; 32(48):6325-9. PubMed ID: 24923636
[TBL] [Abstract][Full Text] [Related]
8. Better vaccines for healthier life. Part II. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
Pagliusi S; Tippoo P; Sivaramakrishnan V; Nguyen T;
Vaccine; 2014 Nov; 32(48):6330-5. PubMed ID: 24923638
[TBL] [Abstract][Full Text] [Related]
9. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
[TBL] [Abstract][Full Text] [Related]
10. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A
Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479
[TBL] [Abstract][Full Text] [Related]
11. Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
Hayman B; Bowles A; Evans B; Eyermann E; Nepomnyashchiy L; Pagliusi S
Vaccine; 2021 Feb; 39(8):1190-1194. PubMed ID: 33487466
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Pagliusi S; Hayman B; Jarrett S
Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
[TBL] [Abstract][Full Text] [Related]
13. Vaccines, our shared responsibility.
Pagliusi S; Jain R; Suri RK;
Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
[TBL] [Abstract][Full Text] [Related]
14. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
Jadhav S; Datla M; Kreeftenberg H; Hendriks J
Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
[TBL] [Abstract][Full Text] [Related]
15. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
[TBL] [Abstract][Full Text] [Related]
16. Sustainable vaccine manufacturing in low- and middle-Income countries.
Hayman B; Kumar Suri R; Downham M
Vaccine; 2022 Nov; 40(50):7288-7304. PubMed ID: 36334966
[TBL] [Abstract][Full Text] [Related]
17. Emerging vaccine manufacturers are innovating for the next decade.
Hayman B; Pagliusi S
Vaccine X; 2020 Aug; 5():100066. PubMed ID: 32462140
[TBL] [Abstract][Full Text] [Related]
18. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children.
CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725
[TBL] [Abstract][Full Text] [Related]
19. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.
Jadhav S; Gautam M; Gairola S
Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201
[TBL] [Abstract][Full Text] [Related]
20. Global equity and timely access: COVID-19 & beyond 23rd DCVMN Annual General Meeting 2022 report.
Suri RK; Liu C; Marini A
Vaccine X; 2023 Dec; 15():100353. PubMed ID: 37533681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
